A phase 1, open-label, perioperative study of ivosidenib (AG-120) and vorasidenib (AG-881) in recurrent, IDH1-mutant, low-grade glioma: Results from Cohort 1 Meeting Abstract
| Authors: | Mellinghoff, I. K.; Wen, P. Y.; Taylor, J. W.; Maher, E. A.; Arrillaga-Romany, I.; Peters, K. B.; Le, K.; Tai, F.; Steelman, L.; Cloughesy, T. F. |
| Abstract Title: | A phase 1, open-label, perioperative study of ivosidenib (AG-120) and vorasidenib (AG-881) in recurrent, IDH1-mutant, low-grade glioma: Results from Cohort 1 |
| Meeting Title: | 14th Meeting of the European Association of Neuro-Oncology (EANO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 21 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2019 Sept 19-22 |
| Meeting Location: | Lyon, France |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-08-01 |
| Start Page: | iii2 |
| Language: | English |
| ACCESSION: | WOS:000493085900006 |
| DOI: | 10.1093/neuonc/noz126.004 |
| PROVIDER: | wos |
| PMCID: | PMC6794942 |
| Notes: | Meeting Abstract: PL3.1 -- Source: Wos |
